Daiwa Securities Group Inc. - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$01450.0%0.00%
Q2 2023$01450.0%0.00%
Q1 2023$0
-100.0%
1450.0%0.00%
Q4 2022$1
-100.0%
1450.0%0.00%
Q3 2022$2,000
+100.0%
1450.0%0.00%
Q2 2022$1,0000.0%1450.0%0.00%
Q1 2022$1,0000.0%1450.0%0.00%
Q4 2021$1,000
-50.0%
1450.0%0.00%
Q3 2021$2,0000.0%145
+101.4%
0.00%
Q2 2021$2,0000.0%720.0%0.00%
Q1 2021$2,000
+100.0%
720.0%0.00%
Q4 2020$1,000
-50.0%
72
-66.0%
0.00%
Q3 2020$2,0000.0%2120.0%0.00%
Q2 2020$2,0000.0%2120.0%0.00%
Q1 2020$2,000
-66.7%
2120.0%0.00%
Q4 2019$6,000
+20.0%
212
-10.9%
0.00%
Q3 2019$5,000
-28.6%
2380.0%0.00%
Q2 2019$7,000
+75.0%
2380.0%0.00%
Q1 2019$4,000
+33.3%
238
+51.6%
0.00%
Q4 2018$3,000
-62.5%
1570.0%0.00%
Q3 2018$8,000
+14.3%
1570.0%0.00%
Q2 2018$7,000
+16.7%
1570.0%0.00%
Q1 2018$6,0001570.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders